You are currently viewing a new version of our website. To view the old version click .
Pharmaceutics
  • Correction
  • Open Access

18 April 2022

Correction: Kazmi et al. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086

,
,
,
,
and
1
Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia
2
Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka 72341, Saudi Arabia
3
School of Pharmacy, Suresh Gyan Vihar University, Jaipur 302017, India
4
Department of Pharmacology, Saveetha Dental College, Saveetha University, Chennai 600077, India
In the original publication [1], there was a mistake in Figure 2 as published. The image of Figure 2 was not clear. The corrected Figure 2 appears below. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original publication has also been updated.
Figure 2. FTIR spectra of the Kaempferol (pure drug) and the prepared Kaempferol nanoparticle.

Reference

  1. Kazmi, I.; Al-Abbasi, F.A.; Afzal, M.; Altayb, H.N.; Nadeem, M.S.; Gupta, G. Formulation and Evaluation of Kaempferol Loaded Nanoparticles against Experimentally Induced Hepatocellular Carcinoma: In Vitro and In Vivo Studies. Pharmaceutics 2021, 13, 2086. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.